Literature DB >> 11382950

Freehand iMRI-guided large-gauge core needle biopsy: a new minimally invasive technique for diagnosis of enhancing breast lesions.

B L Daniel1, R L Birdwell, K Butts, K W Nowels, D M Ikeda, S G Heiss, C R Cooper, S S Jeffrey, F M Dirbas, R J Herfkens.   

Abstract

The lack of reliable methods for minimally invasive biopsy of suspicious enhancing breast lesions has hindered the utilization of contrast-enhanced magnetic resonance imaging (MRI) for the detection and diagnosis of breast cancer. In this study, a freehand method was developed for large-gauge core needle biopsy (LCNB) guided by intraprocedural MRI (iMRI). Twenty-seven lesions in nineteen patients were biopsied using iMRI-guided LCNB without significant complications. Diagnostic tissue was obtained in all cases. Nineteen of the 27 lesions were subsequently surgically excised. Histopathologic analysis confirmed that iMRI-guided LCNB correctly distinguished benign lesions from malignancy in 18 of the 19 lesions. The histology revealed by core biopsy was partially discrepant with surgical biopsy in 2 of the other 19 lesions. Freehand iMRI-guided LCNB of enhancing breast lesions is promising. Larger studies are needed to determine the smallest lesion that can be sampled reliably and to precisely measure the accuracy of iMRI-guided LCNB as a minimally invasive tool to diagnose suspicious lesions found by breast MRI. J. Magn. Reson. Imaging 2001;13:896-902. Copyright 2001 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2001        PMID: 11382950     DOI: 10.1002/jmri.1128

Source DB:  PubMed          Journal:  J Magn Reson Imaging        ISSN: 1053-1807            Impact factor:   4.813


  8 in total

1.  Breast Imaging in Women Previously Irradiated for Hodgkin Lymphoma.

Authors:  Kathleen C Horst; Katherine E Fero; Steven L Hancock; Ranjana H Advani; Debra M Ikeda; Bruce Daniel; Saul A Rosenberg; Sarah S Donaldson; Richard T Hoppe
Journal:  Am J Clin Oncol       Date:  2016-04       Impact factor: 2.339

2.  MRI-guided needle localization of suspicious breast lesions: results of a freehand technique.

Authors:  M A A J van den Bosch; B L Daniel; S Pal; K W Nowels; R L Birdwell; S S Jeffrey; D M Ikeda
Journal:  Eur Radiol       Date:  2006-05-09       Impact factor: 5.315

3.  Comparing deflection measurements of a magnetically steerable catheter using optical imaging and MRI.

Authors:  Prasheel Lillaney; Curtis Caton; Alastair J Martin; Aaron D Losey; Leland Evans; Maythem Saeed; Daniel L Cooke; Mark W Wilson; Steven W Hetts
Journal:  Med Phys       Date:  2014-02       Impact factor: 4.071

4.  MRI-guided intervention for breast lesions using the freehand technique in a 3.0-T closed-bore MRI scanner: feasibility and initial results.

Authors:  Hye Young Choi; Sun Mi Kim; Mijung Jang; Bo La Yun; Sung-Won Kim; Eunyoung Kang; So Yeon Park; Woo Kyung Moon; Eun Sook Ko
Journal:  Korean J Radiol       Date:  2013-02-22       Impact factor: 3.500

Review 5.  [Interventional MRI of the breast. Indications, technique, results and perspectives].

Authors:  K Hellerhoff; T Schlossbauer; P Herzog; M Reiser
Journal:  Radiologe       Date:  2008-04       Impact factor: 0.635

6.  Intraprocedural diffusion-weighted PROPELLER MRI to guide percutaneous biopsy needle placement within rabbit VX2 liver tumors.

Authors:  Jie Deng; Sumeet Virmani; Guang-Yu Yang; Richard Tang; Gayle Woloschak; Reed A Omary; Andrew C Larson
Journal:  J Magn Reson Imaging       Date:  2009-08       Impact factor: 4.813

7.  New device for MRI-guided surgical excision: report of a case.

Authors:  Yuko Tsunoda; Jun-ichi Sanuki; Nobuhito Katayama; Eisuke Fukuma; Kazue Hoshi
Journal:  Surg Today       Date:  2013-05-30       Impact factor: 2.549

8.  Long-term results of screening with magnetic resonance imaging in women with BRCA mutations.

Authors:  K Passaperuma; E Warner; P A Causer; K A Hill; S Messner; J W Wong; R A Jong; F C Wright; M J Yaffe; E A Ramsay; S Balasingham; L Verity; A Eisen; B Curpen; R Shumak; D B Plewes; S A Narod
Journal:  Br J Cancer       Date:  2012-05-15       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.